1. [Combined treatment supported by piracetam and/or acyclovir in idiopathic sudden sensorineural hearing loss: experience with 81 cases].
- Author
-
Karakurt SE, Ozkul MD, Cukurova I, Demirhan E, and Yiğitbaşi OG
- Subjects
- Adolescent, Adult, Aged, Combined Modality Therapy, Female, Hearing Loss, Sensorineural therapy, Hearing Loss, Sudden therapy, Humans, Male, Middle Aged, Neuroprotective Agents therapeutic use, Retrospective Studies, Treatment Outcome, Young Adult, Acyclovir therapeutic use, Antiviral Agents therapeutic use, Hearing Loss, Sensorineural drug therapy, Hearing Loss, Sudden drug therapy, Nootropic Agents therapeutic use, Piracetam therapeutic use
- Abstract
Objectives: To investigate the efficiency of piracetam and acyclovir in treating sudden hearing loss., Patients and Methods: Eightyone patients (44 males, 37 females; mean age 40.4 year; range 18 to 72 years) who had treatment between January 2002 and December 2006 with diagnosis of idiopathic sudden hearing loss were evaluated retrospectively. These patients were divided into four groups according to the treatment they received. The patients who had combined treatment constituted the first group; those who had combined treatment and piracetam the second; those who had combined treatment and acyclovir the third; those who had combined treatment, acyclovir, and piracetam the fourth group., Results: For the four treatment groups, in the pre-and post-treatment (10th day) evaluation of the treatment efficiency made by calculation of the hearing thresholds in 250-8000 Hz frequencies, no significant difference between the groups was determined (p>0.05)., Conclusion: No additional benefit was obtained with acyclovir and piracetam in treatment.
- Published
- 2009